Viscoelastic Hydrogel Scaffold for Spinal Cord Organoid Patterning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing 3D organoids, such as spinal cord organoids, face limitations in achieving specific mature pattern structures, reduced disease modeling accuracy, and inadequate environmental cues for neuronal maturation, leading to a lack of functional complexity and in vivo-like microenvironment.
Innovation Solution
A spinal cord model using a cell scaffold composed of methacrylated hyaluronic acid (HAMA) and dopamine-modified hyaluronic acid (HA-Cat) supports the culture of spinal cord spheroids or organoids that express ventral, dorsal, and interneuron markers, and can be co-cultured with blood vessel spheroids to form a blood-spinal cord barrier model.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If 3D organoids are generated in suspension using current methods, then organoid formation is achieved, but specific mature pattern structure and functional complexity are lacking
Solution Approach 1:
The patent modifies the physical-chemical parameters of the hydrogel scaffold, specifically adjusting viscoelasticity (loss modulus G'' and storage modulus G') to match in vivo tissue properties. By controlling the ratio of methacrylated hyaluronic acid to dopamine-modified hyaluronic acid and varying crosslinking density, the scaffold creates appropriate mechanical cues that guide neuronal differentiation and patterning, resolving the contradiction between achieving precise patterning and maintaining microenvironment simplicity
Solution Approach 2:
The patent employs a composite hydrogel system combining methacrylated hyaluronic acid (for structural integrity and cell adhesion) with dopamine-modified hyaluronic acid (for dynamic viscoelasticity and signaling). This composite material provides both the mechanical support needed for organized patterning and the biochemical complexity required for functional maturation, simultaneously addressing patterning precision and microenvironment complexity
2Productivity
If small molecules are used to induce neuronal cells in 2D culture, then high conversion rate is achieved, but spatial cues for specific cells arranged in 3D structure are insufficient
Solution Approach 1:
The patent introduces a hydrogel scaffold as an intermediary between small molecule induction and 3D spatial organization. The scaffold mediates the transition by providing a three-dimensional matrix with graded biochemical and biomechanical properties that guide cell positioning and differentiation patterns, enabling both high conversion rates and precise spatial arrangement in the resulting organoids
Solution Approach 2:
The patent transitions from 2D planar culture to 3D volumetric culture by embedding cells within a hydrogel scaffold. This dimensional change allows small molecules to diffuse throughout the three-dimensional space while simultaneously providing spatial cues through the scaffold's architecture, resolving the limitation of 2D culture where spatial information is restricted to a single plane
3Adaptability or versatility
If environmental stimulations are applied in 3D organoids, then in vivo-like signaling is improved, but functional maturity and disease modeling accuracy remain reduced
Solution Approach 1:
The patent implements local quality by creating spatially heterogeneous regions within the hydrogel scaffold with different viscoelastic properties and biochemical compositions. Specific zones are optimized for different neuronal subtypes or functional regions, allowing localized environmental stimulations that mimic in vivo tissue heterogeneity and improve both adaptability and disease modeling reliability
Solution Approach 2:
The patent applies preliminary action by pre-configuring the hydrogel scaffold with specific viscoelastic properties and biochemical cues before cell introduction. This pre-establishment of the microenvironment ensures that cells immediately encounter appropriate in vivo-like signaling conditions upon implantation, accelerating maturation and improving disease modeling accuracy without requiring prolonged adaptation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The model enhances the patterning and functional complexity of spinal cord organoids, providing a more in vivo-like microenvironment for improved disease modeling and therapeutic screening.
Implementation Method 1
Viscoelastic hydrogel regulation of organoid patterning and vascularization
Implementation Method 2
a cell scaffold including methacrylated hyaluronic acid (HAMA) and dopamine-modified hyaluronic acid (HA-Cat)
Data Source
AI summary
Disclosed herein are spinal cord models including a cell scaffold including methacrylated hyaluronic acid (HAMA) and dopamine-modified hyaluronic acid (HA-Cat), and a spinal cord spheroid or organoid or a fragment thereof cultured on the cell scaffold. Said spinal cord spheroids or organoids or fragments thereof can be co-cultured with blood vessel spheroid organoids to form blood-spinal cord barrier models. Also disclosed herein are methods of making and using said models.